IGC Pharma Inc [AMEX: IGC] stock went on a downward path that fall over -7.56% on Thursday, amounting to a one-week price decrease of less than -11.69%.
Over the last 12 months, IGC stock rose by 19.64%. The one-year IGC Pharma Inc stock forecast points to a potential upside of 89.14. The average equity rating for IGC stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $28.39 million, with 66.69 million shares outstanding and 52.02 million shares in the current float. Compared to the average trading volume of 220.53K shares, IGC stock reached a trading volume of 2351525 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on IGC Pharma Inc [IGC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IGC shares is $3.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IGC stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for IGC Pharma Inc is set at 0.03, with the Price to Sales ratio for IGC stock in the period of the last 12 months amounting to 26.78. The Price to Book ratio for the last quarter was 3.60, with the Price to Cash per share for the same quarter was set at 0.02.
IGC Stock Performance Analysis:
IGC Pharma Inc [IGC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -11.69. With this latest performance, IGC shares dropped by -19.81% in over the last four-week period, additionally plugging by 39.00% over the last 6 months – not to mention a rise of 19.64% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IGC stock in for the last two-week period is set at 36.24, with the RSI for the last a single of trading hit 31.65, and the three-weeks RSI is set at 39.66 for IGC Pharma Inc [IGC]. The present Moving Average for the last 50 days of trading for this stock 0.4325, while it was recorded at 0.4060 for the last single week of trading, and 0.3910 for the last 200 days.
Insight into IGC Pharma Inc Fundamentals:
IGC Pharma Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.15 and a Current Ratio set at 1.77.
IGC Stock EPS
With the latest financial reports released by the company, IGC Pharma Inc posted -0.4/share EPS, while the average EPS was predicted by analysts to be reported at -0.04/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.36. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IGC.
IGC Pharma Inc [IGC] Institutonal Ownership Details
There are presently around $21.66%, or 23.52%% of IGC stock, in the hands of institutional investors. The top three institutional holders of IGC stocks are: BLACKROCK INC. with ownership of 0.7 million shares, which is approximately 1.1961%. VANGUARD GROUP INC, holding 0.65 million shares of the stock with an approximate value of $$0.28 million in IGC stocks shares; and VANGUARD GROUP INC, currently with $$0.19 million in IGC stock with ownership which is approximately 0.7305%.
